Correlation Between Verrica Pharmaceuticals and Harrow Health

Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Harrow Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Harrow Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verrica Pharmaceuticals and Harrow Health 8625, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Harrow Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Harrow Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Harrow Health.

Diversification Opportunities for Verrica Pharmaceuticals and Harrow Health

-0.73

Correlation Coefficient

Verrica Pharmaceuticals  Harrow Health

Pay attention - limited upside

The 3 months correlation between Verrica and Harrow is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Harrow Health 8625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harrow Health 8625 and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Harrow Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harrow Health 8625 has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Harrow Health go up and down completely randomly.

Pair Corralation between Verrica Pharmaceuticals and Harrow Health

Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 1.46 times less return on investment than Harrow Health. In addition to that, Verrica Pharmaceuticals is 9.23 times more volatile than Harrow Health 8625. It trades about 0.01 of its total potential returns per unit of risk. Harrow Health 8625 is currently generating about 0.08 per unit of volatility. If you would invest  1,971  in Harrow Health 8625 on September 4, 2024 and sell it today you would earn a total of  567.00  from holding Harrow Health 8625 or generate 28.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	99.8%
Values	Daily Returns

Verrica Pharmaceuticals  vs.  Harrow Health 8625

Verrica Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Verrica Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Harrow Health 8625

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Harrow Health 8625 are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Harrow Health is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Verrica Pharmaceuticals and Harrow Health

The main advantage of trading using opposite Verrica Pharmaceuticals and Harrow Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Harrow Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harrow Health will offset losses from the drop in Harrow Health's long position.

The idea behind Verrica Pharmaceuticals and Harrow Health 8625 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.